Paratek Pharmaceuticals, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Paratek Pharmaceuticals, Inc. has filed 1,336 SEC EDGAR filings since 23 Jul 2002

SEC filing history

Showing 26-50 of 199 matching filings.

Per page
25
Current page
2
8-K File 001-36066

8-K

Filing date
18 Oct 2018
Reporting date
16 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

8-K

Filing date
04 Oct 2018
Reporting date
04 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

8-K

Filing date
03 Oct 2018
Reporting date
02 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

8-K

Filing date
08 Aug 2018
Reporting date
08 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

8-K

Filing date
18 Jun 2018
Reporting date
14 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

PROJECT EAGLE CLOSING 8-K

Filing date
23 Apr 2018
Reporting date
17 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

8-K

Filing date
18 Apr 2018
Reporting date
18 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

8-K

Filing date
13 Apr 2018
Reporting date
11 Apr 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

8-K

Filing date
01 Mar 2018
Reporting date
01 Mar 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

8-K

Filing date
19 Jan 2018
Reporting date
17 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

8-K

Filing date
05 Jan 2018
Reporting date
05 Jan 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

8-K

Filing date
04 Aug 2017
Reporting date
03 Aug 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

8-K

Filing date
29 Jun 2017
Reporting date
27 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

8-K

Filing date
16 Jun 2017
Reporting date
15 Jun 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

8-K

Filing date
24 Apr 2017
Reporting date
24 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

8-K

Filing date
03 Apr 2017
Reporting date
03 Apr 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

8-K

Filing date
27 Mar 2017
Reporting date
27 Mar 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

8-K

Filing date
08 Feb 2017
Reporting date
02 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

8-K

Filing date
09 Jan 2017
Reporting date
09 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

8-K

Filing date
04 Jan 2017
Reporting date
04 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

8-K

Filing date
13 Dec 2016
Reporting date
12 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36066

FORM 8-K

Filing date
22 Jun 2016
Reporting date
21 Jun 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .